Vasogen
<< Back
Chronic Heart Failure

Chronic heart failure, most frequently resulting from coronary artery disease or hypertension, is a debilitating condition in which the heart’s ability to function as a pump is impaired. Patients with heart failure experience a continuing decline in their health, resulting in an increased frequency of hospitalization and premature death. In North America alone, heart failure affects more than five million people and is associated with more than 300,000 deaths each year. The direct healthcare cost, primarily resulting from hospitalization, is estimated to exceed $30 billion annually. These statistics suggest that important pathological mechanisms, including inflammation, remain active and unmodified by the available therapies, particularly when the disease has reached advanced stages.



ECGVasogen is developing immune modulation therapy to target chronic inflammation—a key pathological process not addressed by current heart failure therapies.


For additional information, please visit the following Web sites:





More than 5 million people in North America have chronic heart failure. Each year, 300,000 deaths are associated with heart failure and healthcare costs estimated to exceed $30 billion.